Myda Advisors LLC Kura Oncology, Inc. Transaction History

Myda Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$17.53 - $22.98 $105,180 - $137,880	-6,000 Reduced 23.08%	20,000 $411,000
Q1 2024 May 14, 2024	BUY	$13.42 - $23.53 $13,420 - $23,530	1,000 Added 4.0%	26,000 $554,000
Q4 2023 Feb 13, 2024	SELL	$7.58 - $14.38 $416,900 - $790,900	-55,000 Reduced 68.75%	25,000 $359,000
Q2 2023 Aug 11, 2023	BUY	$9.62 - $13.99 $577,200 - $839,400	60,000 Added 300.0%	80,000 $846,000
Q1 2022 May 13, 2022	BUY	$11.78 - $16.98 $235,600 - $339,600	20,000 New	20,000 $322,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Myda Advisors LLC with notifications on news.